Atlas Trials

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Clinical trial NCT01336933 · COMPLETED

Trial details

NCT number
NCT01336933
Sponsor
University of Nebraska
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell LymphomaPeripheral T-cell Lymphoma
Start date
2011-07-06
Primary completion
2016-12-28
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.